Acasti Pharma reported $-2.53M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Acasti Pharma USD -2.53M 560K Sep/2025
Addus HomeCare USD 39.82M 876K Sep/2026
Amarin USD -2.26M 564K Dec/2025
Cassava Sciences USD -9.39M 1.78M Jun/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Option Care Health USD 89.22M 4.08M Sep/2026
Organigram Holdings CAD 5.33M 15.12M Jun/2026
Tilray USD -20.01M 9.34M Sep/2025